IRIDEX Co. (NASDAQ:IRIX – Get Free Report) was the target of a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 309,800 shares, a decrease of 8.0% from the October 15th total of 336,800 shares. Approximately 2.5% of the company’s shares are short sold. Based on an average daily trading volume, of 25,000 shares, the short-interest ratio is presently 12.4 days.
IRIDEX Trading Up 4.1 %
Shares of NASDAQ IRIX opened at $1.76 on Tuesday. The company’s 50 day simple moving average is $1.67 and its 200 day simple moving average is $2.01. IRIDEX has a fifty-two week low of $1.27 and a fifty-two week high of $3.65. The firm has a market capitalization of $29.28 million, a P/E ratio of -2.63 and a beta of 0.80. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.54 and a quick ratio of 0.86.
IRIDEX (NASDAQ:IRIX – Get Free Report) last posted its earnings results on Tuesday, November 12th. The medical equipment provider reported ($0.12) earnings per share for the quarter. The firm had revenue of $11.58 million during the quarter. IRIDEX had a negative return on equity of 192.95% and a negative net margin of 22.79%. During the same quarter in the previous year, the business posted ($0.11) EPS.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on IRIDEX
About IRIDEX
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.
Featured Articles
- Five stocks we like better than IRIDEX
- Using the MarketBeat Dividend Yield Calculator
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Applied Materials Market Capitulates: Now is the Time to Buy
- NYSE Stocks Give Investors a Variety of Quality Options
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for IRIDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX and related companies with MarketBeat.com's FREE daily email newsletter.
